The most comprehensive and go-to place for all short selling reseach reports online.
Currently a total of 275 research reports from 14 investment research firms has been aggregated, with new reports being added and updated constantly
ALL
Fuzzy Panda Research(8)
Hindenburg Research(52)
MuddyWaters(44)
Blue Orca Capital(35)
Gotham City Research LLC(11)
Anonymous Analytics(5)
J Capital Research(26)
Grizzly Research LLC(22)
Jehoshaphat Research(10)
Culper Research(20)
Ningi Research(4)
Night Market Research(14)
Ontake Research(2)
Bonitas Research(22)
https://www.jcapitalresearch.com/index.html
https://www.jcapitalresearch.com/index.html
Current Share Price: 134.820
J Capital Research
Initial Report Date(2019/09/05)Share Price:140.560
Initial Report Date(2019/09/05)Share Price:140.560
BeiGene, Ltd. (BGNE US) No Cure BeiGene May Be Faking 60% of Sales
Details Link > BeiGene is still pumping and dumping. With a chaotic, over-priced, and ineffectual
R&D program for me-too drugs, BeiGene is trying to excite the market and prop up
share price by posting high growth in sales of drugs on behalf of Celgene (CELG).
But our research indicates that these sales reports are simply a lie
By wantattse
Subsequent Report (2019/09/11)Share Price:127.450
BeiGene, Ltd. (BGNE US) Digging a Deeper Hole
Details Link > BeiGene’s September 8 investor call was heavy on declarations of the
company’s integrity and light on facts.
In attempting to rebut our findings, BeiGene made a number of statements that are provably false. On several occasions they failed to refute
our core assertions. In fact, they confirmed some of them.
The call wasn’t all bad. We want to praise the company for finally disclosing that it uses an exclusive distributor for all drug sales in China,
a fact that had been hidden from investors for the three and a half years
the company has been listed. We also want to commend BeiGene for admitting that it has inventory of Celgene drugs in China. Since BeiGene
buys from Celgene then sells all the drugs to its distributor, China Resources, offshore, any inventory in China has to have been repurchased
from China Resources. That is round-tripping, plain and simple
By wantattse
Start